Sichuan Kelun Pharmaceutical Co Ltd (002422.SZ)
20 Jan 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- BRIEF-Sichuan Kelun Pharmaceutical to raise 35 pct stake in biotechnology firm and to fully buy pharmaceutical unit
- BRIEF-Sichuan Kelun Pharmaceutical sees 2016 net profit down 10 pct to up 20 pct
- BRIEF-Sichuan Kelun Pharmaceutical unit fully buys KLUS PHARMA INC. for $12.82 mln
- BRIEF-Sichuan Kelun Pharmaceutical issues 2016 1st short-term financing notes worth 500 mln yuan
- BRIEF-Sichuan Kelun Pharmaceutical to issue 1.8 bln yuan 5-YR bonds